Since their development and widespread adoption in the late 1980s, proton pump inhibitors (PPI) have transformed the field of gastroenterology. Their high efficacy and favorable safety profiles have ...

Global Proton Pump Inhibitors Market is estimated to be valued at USD 4.02 Bn in 2025 and is expected to reach USD 5.90 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.6% from 2025 to ...

For acute intracerebral hemorrhage, intensive blood pressure lowering was consistently linked to less neurological deterioration and better physical function without evidence of hematoma growth on CT, ...

Proton pump inhibitor use is implicated in decline in kidney graft function after transplantation. Extended proton pump inhibitor (PPI) use is associated with decline in graft function in kidney ...

Proton pump inhibitors (PPIs), widely prescribed for acid-related disorders like GERD and peptic ulcers, are associated with significant adverse effects when used long-term. This review highlights ...

TOKYO, Jun 2, 2025 - (JCN Newswire) - - Eisai Co., Ltd. announced today the launch of "Pariet S" (pharmaceutical requiring guidance), which is highly effective in alleviating severe heartburn ...

DEAR DR. ROACH: I am a 71-year-old male in good health. I read your recent column on the use of proton-pump inhibitors (PPIs). About eight years ago, I was hospitalized for 10 days due to a severe ...

Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate stomach problems. PPIs are activated in the acid-producing cells of the ...

Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate stomach problems. PPIs are activated in the acid-producing cells of the ...

Use of proton pump inhibitors appears to increase the risk for kidney failure among patients with CKD. Use of proton pump inhibitors (PPIs) may spur progression to kidney failure in patients with ...